TEMT is an investigational device currently under clinical development and currently not available for purchase. NeuroEM’s Pivotal clinical trial is anticipated to begin enrollment in Fall 2022, initially at approximately 3-4 clinical trial locations in the U.S.(not yet being disclosed). Please check this website regularly for announcements regarding when the company’s upcoming clinical trial will begin recruitment.

NeuroEM Therapeutics, Inc.
501 E. Kennedy Blvd., #650
Tampa, Florida 33602

  • This field is for validation purposes and should be left unchanged.